Clene (CLNN) Receives Buy Recommendation and Sees 235.17% Upside Potential

D. Boral Capital maintains a Buy recommendation for Clene (CLNN) with a projected annual revenue of $53MM and a non-GAAP EPS of -$0.59. The average one-year price target is $31.04/share, representing a 235.17% increase from its latest closing price of $9.26/share. There are 38 funds or institutions reporting positions in Clene, with an average portfolio weight of 0.01%.